As a crypto investor with a background in biotech and a deep interest in the potential of emerging technologies, I’m thrilled to see Tether, the issuer of USDT, the largest stablecoin by market capitalization, making strategic moves beyond their core business. The recent announcement of their $200 million investment in Blackrock Neurotech, a brain-computer interface (BCI) developer, is a game-changer in my opinion.
As a researcher investigating recent developments in the stablecoin market, I came across an intriguing announcement from Tether, the prominent USDT provider. On Monday, they disclosed that they allocated $200 million to acquire a significant stake in Blackrock Neurotech through Tether Evo, their venture capital arm. This move signifies Tether’s expansion into brain-computer interface technology development.
Blackrock Neurotech is a tech firm pioneering medical devices that harness brain signals to aid individuals afflicted by neurological disorders and paralysis. Despite the similar name, there’s no connection between Blackrock Neurotech and the financial heavyweight, BlackRock.
Tether aspires to facilitate the promotion and deployment of medical innovations that have improved the health of over forty patients. In addition, Blackrock Neurotech intends to utilize the funding to remain a leading player in the Brain-Computer Interface (BCI) sector, with a sustained commitment to human advancement.
The Blackrock Neurotech is committed to helping millions of people globally who struggle with neurological disorders, paralysis, impaired functions, and other conditions that hinder their ability to walk, see, hear, sense touch, or communicate effectively.
Tether, the organization responsible for USDT – the leading stablecoin boasting a market cap of $110 billion – has recently established four separate entities to expand their operations beyond the realm of stablecoins.
I, as an observer, believe that Paolo Ardoino, the CEO of Tether, holds a strong conviction in fostering innovative technologies capable of significant impact. Specifically, he sees great potential in Blackrock Neurotech’s Brain-Computer Interfaces (BCIs) to revolutionize communication, rehabilitation, and cognitive enhancement.
“He commented, ‘Blackrock Neurotech signifies progress toward a time when tech seamlessly improves our human existence. We at Tether are thrilled to embark on this adventure together.’ “
Florian Solzbaker, co-founder of Blackrock Neurotech, emphasized that the company’s mission to help people restore their abilities is a prolonged endeavor requiring dedicated and innovative collaborators.
Read More
Sorry. No data so far.
2024-04-29 17:40